Positive updates across all programs, including updates from ongoing clinical studies and new translational data in preclinical models ...
Beam Therapeutics unveiled BEAM-101 trial data at ASH, showing improved outcomes in sickle cell patients and promising ...
Rami Katkhuda, an analyst from LifeSci Capital, maintained the Buy rating on Disc Medicine (IRON – Research Report). The associated price ...
J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH ...
Beam Therapeutics reported promising trial data from seven sickle cell patients treated with their gene-edited therapy, ...
Thalassemia is a condition in which the body makes less hemoglobin, a protein that's an important part of red blood cells. This results in red blood cells being destroyed, which is known as hemolytic ...
Neonatal anemia can have lasting impacts on the growth and development of children. Anemia is highly prevalent among pregnant ...
Though he doesn't remember it, Branden Baptiste had his first sickle cell crisis at age 2. Through elementary school, he was ...
Though he doesn't remember it, Branden Baptiste had his first sickle cell crisis at age 2. Through elementary school, he was ...
Promising topline results from a phase 3B study show the efficacy and quality of life (QOL) improvements of iptacopan ...
Everyday Health on MSN3 天
Sickle Cell Anemia Symptoms
The hallmark symptom of sickle cell anemia is pain, particularly episodes of sudden pain, sometimes called sickle cell crises ...
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.